Swiss National Bank acquired a new position in Genpact Limited (NYSE:G – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 332,900 shares of the business services provider’s stock, valued at approximately $14,298,000.
Several other hedge funds have also recently bought and sold shares of the company. SRH Advisors LLC acquired a new position in Genpact during the 4th quarter worth $26,000. Manchester Capital Management LLC bought a new stake in shares of Genpact during the fourth quarter valued at about $38,000. Smartleaf Asset Management LLC lifted its holdings in Genpact by 416.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock worth $41,000 after purchasing an additional 783 shares during the period. UMB Bank n.a. grew its position in Genpact by 55.7% in the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after buying an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp increased its stake in Genpact by 38.8% during the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider’s stock valued at $69,000 after buying an additional 453 shares during the period. 96.03% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other news, SVP Piyush Mehta sold 12,000 shares of the company’s stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares in the company, valued at $6,475,125.06. This represents a 7.35 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the sale, the chief executive officer now owns 310,246 shares of the company’s stock, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 2.80% of the company’s stock.
Genpact Stock Performance
Genpact (NYSE:G – Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, equities analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be given a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 1.33%. The ex-dividend date is Tuesday, March 11th. This is an increase from Genpact’s previous quarterly dividend of $0.15. Genpact’s dividend payout ratio is 23.94%.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on G shares. TD Cowen raised shares of Genpact from a “hold” rating to a “buy” rating and upped their price target for the stock from $45.00 to $60.00 in a research note on Friday, February 7th. Needham & Company LLC upped their target price on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and lifted their price target for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, Mizuho upped their price objective on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Six analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, Genpact currently has a consensus rating of “Hold” and an average price target of $48.44.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles
- Five stocks we like better than Genpact
- Short Selling – The Pros and Cons
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- 3 Healthcare Dividend Stocks to Buy
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Why is the Ex-Dividend Date Significant to Investors?
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.